{"id":14519,"date":"2021-08-19T12:52:11","date_gmt":"2021-08-19T12:52:11","guid":{"rendered":"https:\/\/interhospi.com\/?p=14519"},"modified":"2021-08-19T12:52:11","modified_gmt":"2021-08-19T12:52:11","slug":"researchers-start-new-investigation-into-long-covid-core-outcome-set","status":"publish","type":"post","link":"https:\/\/interhospi.com\/researchers-start-new-investigation-into-long-covid-core-outcome-set\/","title":{"rendered":"Researchers start new investigation into Long Covid core outcome set"},"content":{"rendered":"
<\/p>\n
<\/p>\n
<\/p>\n
The World Health Organization (WHO) recently called on countries to prioritise recognition, rehabilitation and research for the consequences of Covid-19, and the collection of standardised data on Long Covid. They proposed the term \u201cPost Covid-19 Condition\u201d should be used for people living with Long Covid.<\/p>\n
A significant portion of people diagnosed with Covid-19 subsequently experience lasting symptoms including fatigue, breathlessness and neurological complications months after the acute infection. However, the evidence for this condition is limited and based on small patient cohorts with short-term follow-up.<\/p>\n
There is an urgent need for the development of a core outcome set (COS) to optimise and standardise clinical data collection and reporting across studies (especially clinical trials) and clinical practice for this condition. With this in mind, clinical research communities and people living with Post Covid-19 Condition have come together to respond to this emerging global healthcare crisis.<\/p>\n
An international group of experts in COS development and Post Covid-19 Condition research and clinical practice have developed a programme of research together with WHO, ISARIC (International Severe Acute Respiratory and emerging Infection Consortium), and patient partners to develop a Post Covid-19 Condition COS.<\/p>\n